Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
...at http://www.decode.com ; on our diagnostics site at http://www.decodediagnostics.com ; for our pioneering personal genome analysis service and new cardio and Cancer scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at http://www.decodeme...deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
...at http://www.decode.com ; on our diagnostics site at http://www.decodediagnostics.com ; for our pioneering personal genome analysis service and new cardio and Cancer scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at http://www.decodeme...deCODE Sells Auction Rate Securities
...us on the web at www.decode.com ; on our diagnostics site at www.decodediagnostics.com ; for our pioneering personal genome analysis service and new cardio and Cancer scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at www.decodeme.com ; ...CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
...OTC Bulletin Board: CVBT) (the "Company") has entered into its first clinical development agreement for its Coronary Heart Disease drug candidate with cardio Neo-Genesis, LP ("CNG"). The agreement, dated November 11, 2008 states that CNG can fund up to $15,000,000 of the clinical development for the Company...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...hange Copenhagen: GEN) KYOWA HAKKO KOGYO (Tokyo SE: 4151) MERCK KGAA (Frankfurt, Germany: MRK) YAKULT HONSHA CO (Tokyo SE: 2267) HealthShares(TM) cardio Devices Index (HHE) Drop ANGIODYNAMICS INC. (NASDAQ: ANGO ) ATRION CORPORATION (NASDAQ: ATRI ) BOSTON SCIENTIFIC CORP. (NYSE: BSX ) CARDIAC ...Two New Appointments at Meditor Pharmaceuticals Ltd.
...Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials. Dr. Adrian Harel joined Meditor in January 2008. He combines a broad sc...CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
...ard: CVBTE) has entered into an agreement with Mr. Phillip Frey Jr. to form cardio Derma Clinical Partners (CDCP), an R&D Partnership. Mr. Frey, as sponsor an...ns on their investments," said Mr. Phillip Frey Jr. He continued, "CVBT and cardio Derma Clinical Partners are going back to these basics in an effort to adva...CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
...CryoLife as a major distribution partner. CryoLife is a world leader in its chosen areas, and its strength in sales, marketing and distribution in the cardio and vascular fields should provide great impetus to Medafor's market penetration." The agreement allows for a three-year extension at the option of ...Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
...umor progression have not been excluded when ESAs are dosed to target a hemoglobin of -- To minimize these risks, as well as the risk of serious cardio -- and thrombovascular events, use the lowest dose needed to avoid red blood cell transfusions. -- Use only for treatment of anemia due to co...EaglePicher Technologies Receives Battery Power Products and Technology's First Annual Innova Award
...r EaglePicher Medical Power is a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems. EaglePicher Medical Power is one of the few producers of implant...Heart patients benefit from digital image network
...ove patient care. VERCIS acquires and stores imaging studies generated in each hospitals echocardiography labs, giving physicians network access to cardio data for review and diagnosis. The VERICIS systems at each hospital are connected by a high-speed digital communication link which facilitates study s...Thomson lends perspective to stem cell expectations
... Timothy Kamp. The company plans to introduce a test for drug candidates for heart toxicity, and hopes to do limited cardiac toxic testing in human cardio myocytes - beating heart cells - in the first quarter of next year. "It's Craig January's prior work," Thomson said. "Craig offers the gold standar...